Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05518110
Title PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer (PaTcH)
Acronym PaTcH
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cancer Trials Ireland
Indications
Therapies
Age Groups: adult | senior
Covered Countries IRL


No variant requirements are available.